At the pharmacologically active concentration of 5 μM tamoxifen, overexpression of miR-181a-5p led to the suppression of OSBPL3 expression, which in turn inhibited the invasion, migration, and proliferation of BC cells, while increasing their apoptosis. Here, OSBPL3 is linked to breast cancer.